GoodRx Holdings logo

GoodRx HoldingsNASDAQ: GDRX

Profile

Sector:

Healthcare

Country:

United States

IPO:

23 September 2020

Next earnings report:

07 November 2024

Last dividends:

N/A

Next dividends:

N/A
$2.40 B
-86%vs. 3y high
83%vs. sector
-vs. 3y high
-vs. sector
-83%vs. 3y high
74%vs. sector
-88%vs. 3y high
48%vs. sector

Price

after hours | Fri, 01 Nov 2024 23:33:34 GMT
$6.33+$0.14(+2.26%)

Dividend

No data over the past 3 years
$200.61 M$195.65 M
$200.61 M$6.69 M

Analysts recommendations

Institutional Ownership

GDRX Latest News

Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm
globenewswire.com31 October 2024 Sentiment: NEGATIVE

NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of GoodRx Holdings, Inc. (NASDAQ: GDRX) breached their fiduciary duties to shareholders.

GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call
businesswire.com10 October 2024 Sentiment: POSITIVE

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its third quarter 2024 financial results before U.S. markets open on Thursday, November 7, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's business outlook. To access the conference.

ELV vs. GDRX: Which Stock Is the Better Value Option?
zacks.com08 October 2024 Sentiment: NEUTRAL

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks presents investors with the better value opportunity right now?

GoodRX Subscription Revenue Down 8% but Active User Numbers Are Up
pymnts.com08 August 2024 Sentiment: POSITIVE

It was a mixed bag of growth and challenges for digital healthcare platform GoodRx during the second quarter. In reporting its second-quarter results Thursday (Aug. 8), GoodRx said monthly active users (MACs) rose 8%, contributing to a 7% rise in prescription transactions revenue, which totaled $146.7 million.

GoodRx Holdings, Inc. (GDRX) Misses Q2 Earnings and Revenue Estimates
zacks.com08 August 2024 Sentiment: NEUTRAL

GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.07 per share a year ago.

GoodRx Reports Q2 Earnings With Increased Prescription Revenue But Subscription Challenges
benzinga.com08 August 2024 Sentiment: POSITIVE

Prescription savings platform GoodRx Holdings Inc. GDRX reported second-quarter revenue of $200.61 million, up 6% year over year, almost in line with the consensus of $200.4 million.

GoodRx Q2 Earnings Preview
seekingalpha.com31 July 2024 Sentiment: NEGATIVE

GoodRx stock rated a sell due to industry headwinds, cost growth outpacing revenue, and needing 12%+ growth to justify price. Q2 earnings expected to be in line with guidance, but long-term guidance doesn't support current price point. Upside potential if GoodRx doubles market growth, but industry headwinds and growth struggles pose challenges.

Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira®
prnewswire.com18 July 2024 Sentiment: POSITIVE

First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif.

3 Lawsuit-Laden Stocks to Dump Before Problems Multiply
investorplace.com10 July 2024 Sentiment: NEGATIVE

A pending or ongoing lawsuit isn't always a reliable indicator of stocks to sell, but, in many cases, investors should take litigation as a sign to dig beneath the surface. I'd first caution retail investors not to take pending litigation as a sure sign of failure or risk; tons of legal firms push frivolous lawsuits in a bid to maximize their own income.

Drug prices have risen almost 40% over the last decade, according to a new tracker
cnbc.com27 June 2024 Sentiment: NEGATIVE

The cost of prescription medications in the U.S. has increased by 37% since 2014, far surpassing the rate of inflation, according to data from drug savings company GoodRx. Though the price increases have slowed this year in comparison with the past decade, the average American spends $16.26 out of pocket per prescription, according to the data.

What type of business is GoodRx Holdings?

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

What sector is GoodRx Holdings in?

GoodRx Holdings is in the Healthcare sector

What industry is GoodRx Holdings in?

GoodRx Holdings is in the Health Information Services industry

What country is GoodRx Holdings from?

GoodRx Holdings is headquartered in United States

When did GoodRx Holdings go public?

GoodRx Holdings initial public offering (IPO) was on 23 September 2020

What is GoodRx Holdings website?

https://www.goodrx.com

Is GoodRx Holdings in the S&P 500?

No, GoodRx Holdings is not included in the S&P 500 index

Is GoodRx Holdings in the NASDAQ 100?

No, GoodRx Holdings is not included in the NASDAQ 100 index

Is GoodRx Holdings in the Dow Jones?

No, GoodRx Holdings is not included in the Dow Jones index

When was GoodRx Holdings the previous earnings report?

No data

When does GoodRx Holdings earnings report?

The next expected earnings date for GoodRx Holdings is 07 November 2024